Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
FDA warns homeopathic firm; FDA deems “no complaints” inadequate response; NAD questions urinary control claims; Refunds for Disney and Marvel vitamins; more regulatory news in brief.
You may also be interested in...
In Brief
BASF casts bid for Pronova BioPharma; Bayer will not top Reckitt’s Schiff bid; FDA expands arsenal against tainted supplements; CHPA launches anti-smurfing initiative; Bovine ingredients trip Atrium; more news in brief.
Supplement Demographic Expansion Drives Emerging Category Growth
Consumers’ reasons for using supplements and the delivery formats they prefer are growing. Emerging growth categories include natural supplements and those aimed at heart health, diabetes and muscle-retention.
Supplement Demographic Expansion Drives Emerging Category Growth
Consumers’ reasons for using supplements and the delivery formats they prefer are growing. Emerging growth categories include natural supplements and those aimed at heart health, diabetes and muscle-retention.